节点文献
中国多巴胺能PET联合葡萄糖代谢PET脑显像在帕金森病临床应用专家共识
Consensus on Clinical Application of “Dopaminergic-glucose” United PET Imaging in Parkinsonian Disorders in China
【摘要】 多巴胺能正电子发射断层扫描(PET)脑显像是目前诊断帕金森病的重要依据,但其对帕金森综合征的鉴别能力有限。葡萄糖代谢PET显像中不同的脑代谢模式为进一步鉴别诊断提供可能。文中在前期PET脑显像相关技术操作和临床应用专家共识的基础上,对开展多巴胺能联合葡萄糖代谢显像进行系统梳理,征求专家意见后形成本专家共识。旨在规范帕金森综合征患者的多巴胺能显像及葡萄糖代谢显像的技术操作,为医生提供报告解读建议,进一步指导多巴胺能与葡萄糖代谢PET脑显像联合应用在帕金森相关疾病中的临床实践流程。
【Abstract】 Dopaminergic positron emission computed tomography(PET) has been validated as an important supportive and exclusive criteria for the diagnosis of Parkinson’s disease. However, it is limited in the differential diagnosis of different kinds of parkinsonism. The different cerebral metabolic patterns in 18F-fluorodeoxyglucose PET imaging can facilitate the further differential diagnosis. Based on the previously published expert consensus for the operation procedure and clinical application of PET imaging, this expert consensus was formed after systematic combing of dopaminergic and glucose metabolism imaging. This consensus aimed to standardize the operation procedures of dopaminergic and glucose metabolism PET in parkinsonism, providing suggestions for the report interpretations, and further guiding the clinical practice using the “dopaminergic-glucose” united PET imaging in parkinsonism.
【Key words】 parkinsonism; Parkinson’s disease; positron emission computed tomography; dopaminergic imaging; glucose metabolism imaging; combination;
- 【文献出处】 中国临床神经科学 ,Chinese Journal of Clinical Neurosciences , 编辑部邮箱 ,2024年04期
- 【分类号】R742.5
- 【下载频次】26